Skip to main content
Log in

Zwolle risk score predicts contrast-induced acute kidney injury in STEMI patients undergoing PCI

Zwolle-Risikoscore als Prädiktor der kontrastmittelinduzierten akuten Niereninsuffizienz bei STEMI-Patienten nach PCI

  • e-Herz: Original article
  • Published:
Herz Aims and scope Submit manuscript

Abstract

Objective

Contrast-induced acute kidney injury (CI-AKI) is a common complication in patients with acute ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). The Mehran risk score was defined originally in elective PCI and may be predictive of CI-AKI. The aim of the present study was to investigate whether the Zwolle score predicts CI-AKI in patients with acute STEMI undergoing primary PCI.

Patients and methods

We analyzed the data of 314 consecutive patients (mean age 56.3 ± 11.4 years) with acute STEMI undergoing primary PCI. The study population was divided into two groups according to CI-AKI development. The Mehran score, Zwolle score, baseline characteristics, and in-hospital outcomes were recorded.

Results

Patients with CI-AKI had higher Mehran and Zwolle scores. In a receiver operating characteristic (ROC) curve analysis, high area under the curve (AUC) values were determined for Zwolle and Mehran scores (0.85 and 0.79, respectively) for CI-AKI development. A Zwolle score greater than  2 predicted CI-AKI with a sensitivity of 76.3 % and a specificity of 75.4 %. A Mehran score greater than 5 predicted CI-AKI with a sensitivity of 71.1 % and a specificity of 73.6 %.

Conclusion

Zwolle score predicts CI-AKI slightly better than the Mehran score in patients with STEMI undergoing primary PCI. This simple score can be used at the catheterization laboratory for risk stratification for the development of CI-AKI.

Zusammenfassung

Ziel

Die kontrastmittelinduzierte akute Niereninsuffizienz (CI-AKI) ist eine häufige Komplikation bei Patienten mit akutem ST-Hebungs-Infarkt (STEMI), bei denen eine primäre perkutane Koronarintervention (PCI) erfolgt. Der Mehran-Risikoscore war ursprünglich für die elektive PCI definiert und kann eine CI-AKI vorhersagen. Ziel der vorliegenden Studie war es zu untersuchen, ob sich mit dem Zwolle-Score eine CI-AKI bei Patienten mit akutem STEMI und primärer PCI vorhersagen lässt.

Patienten und Methoden

Die Daten von 314 konsekutiven Patienten (Durchschnittsalter: 56,3 ± 11,4 Jahre) mit akutem STEMI und Durchführung einer primären PCI wurden ausgewertet. Die Studienpopulation wurde je nach Auftreten einer CI-AKI oder nicht in 2 Gruppen aufgeteilt. Der Mehran-Score, der Zwolle-Score, Merkmale zu Studienbeginn und Ergebnisse während der stationären Behandlung wurden dokumentiert.

Ergebnisse

Patienten mit CI-AKI wiesen einen höheren Mehran- und Zwolle-Score auf. Bei der Receiver-operating-Characteristic(ROC)-Kurven-Analyse wurden hohe Werte für die Fläche unter der Kurve (AUC) im Zwolle- und Mehran-Score (0,85 bzw. 0,79) in Bezug auf die Entwicklung einer CI-AKI festgestellt. Ein Zwolle-Score > 2 war mit einer Sensitivität von 76,3 % und einer Spezifität von 75,4 % ein Prädiktor für eine CI-AKI. Ein Mehran-Score > 5 sagte eine CI-AKI mit einer Sensitivität von 71,1 % und einer Spezifität von 73,6 % voraus.

Schlussfolgerung

Mit dem Zwolle-Score lässt sich bei Patienten mit STEMI, bei denen eine primäre PCI erfolgt, eine CI-AKI etwas besser als mit dem Mehran-Score voraussagen. Dieser einfache Risikoscore kann zur Risikostratifizierung für das Auftreten einer CI-AKI im Katheterlabor eingesetzt werden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Rihal CS, Textor SC, Grill DE et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264

    Article  PubMed  Google Scholar 

  2. McCullough P (2006) Contrast induced nephropathy: experience in patients undergoing cardiovascular intervention. Catheter Cardiovasc Interv 67:335–343

    Article  PubMed  Google Scholar 

  3. Barrett BJ, Parfrey PS (2006) Clinical practice: preventing nephropathy induced by contrast medium. N Engl J Med 354:379–386

    Article  CAS  PubMed  Google Scholar 

  4. Zijlstra F, Hoorntje JCA, De Boer MJ et al (1999) Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 341:1413–1419

    Article  CAS  PubMed  Google Scholar 

  5. Marenzi G, Lauri G, Assanelli E et al (2004) Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44:1780–1785

    Article  PubMed  Google Scholar 

  6. Senoo T, Motohiro M, Kamihata H et al (2010) Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol 105:624–628

    Article  PubMed  Google Scholar 

  7. Mehran R, Aymong ED, Nikolsky E et al (2004) A simple risk score for prediction of contrast- induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393–1399

    PubMed  Google Scholar 

  8. De Luca G, Suryapranata H, Hof AW van’t et al (2004) Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation 109:2737–2743

    Article  Google Scholar 

  9. Stevens LA, Coresh J, Greene T, Levey AS (2006) Assessing kidney functionmeasured and estimated glomerular filtration rate. N Engl J Med 354:2473–2483

    Article  CAS  PubMed  Google Scholar 

  10. Schiller NB, Shah PM, Crawford M et al (1989) Recommendations for quantitation of the left ventricle by twodimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two- Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358–367

    Article  CAS  PubMed  Google Scholar 

  11. Chesebro JH, Knatterud G, Roberts R et al (1987) Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 76:142–154

    Article  CAS  PubMed  Google Scholar 

  12. Mehran R, Dangas G, Abizaid AS et al (1999) Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100(18):1872–1878

    Article  CAS  PubMed  Google Scholar 

  13. Garg S, Serruys PW, Silber S et al (2011) The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial. JACC Cardiovasc Interv 4(4):432–441

    Article  PubMed  Google Scholar 

  14. Bellomo R, Ronco C, Kellum JA et al (2004) Acute Dialysis Quality Initiative workgroup: acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204–R212

    Article  PubMed  PubMed Central  Google Scholar 

  15. Mehta RL, Kellum JA, Shah SV et al (2007) Acute kidney injury network: acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31

    Article  PubMed  PubMed Central  Google Scholar 

  16. Cutlip DE, Windecker S, Mehran R et al (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115(17):2344–2351

    Article  PubMed  Google Scholar 

  17. Thygesen K, Alpert JS, Jaffe AS et al (2012) Joint ESC/ACCF/AHA/WHF task force for the universal definition of myocardial infarction. Third universal definition of myocardial infarction. Eur Heart J 33(20):2551–2567

    Article  PubMed  Google Scholar 

  18. Thiele H, Hildebrand L, Schirdewahn C et al (2010) Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single- Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial. J Am Coll Cardiol 55:2201–2209

    Article  CAS  PubMed  Google Scholar 

  19. Marenzi G, Assanelli E, Campodonico J et al (2010) Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission. Crit Care Med 38:438–444

    Article  PubMed  Google Scholar 

  20. Tepel M, Aspelin P, Lameire N (2006) Contrast-induced nephropathy: a clinical and evidence- based approach. Circulation 113:1799–1806

    Article  PubMed  Google Scholar 

  21. Tumlin J, Stacul F, Adam A et al (2006) CIN Consensus Working Panel:pathophysiology of contrast-induced nephropathy. Am J Cardiol 98:14–20

    Article  Google Scholar 

  22. Uyarel H, Cam N, Ergelen M et al (2009) Contrast induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction: incidence, a simple risk score, and prognosis. Arch Med Sci 5:550–558

    Google Scholar 

  23. Wi J, Ko YG, Kim JS et al (2011) Impact of contrast- induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart 97:1753–1757

    Article  PubMed  Google Scholar 

  24. Briguori C, Airoldi F, D’Andrea D et al (2007) Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 115:1211–1217

    CAS  PubMed  Google Scholar 

  25. Solomon R, Werner C, Mann D et al (1994) Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416–1420

    Article  CAS  PubMed  Google Scholar 

  26. ACT Investigators (2011) Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation 124:1250–1259

    Article  Google Scholar 

  27. Kelly AM, Dwamena B, Cronin P et al (2008) Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy: Ann Intern Med 148:284–294

    Google Scholar 

  28. Hsiao PG, Hsieh CA, Yeh CF et al (2012) Early prediction of acute kidney injury in patients with acute myocardial injury. J Crit Care 27:525

    Article  PubMed  Google Scholar 

  29. Perrin T, Descombes E, Cook S (2012) Contrast-induced nephropathy in invasive cardiology. Swiss Med Wkly 142:w13608

    PubMed  Google Scholar 

  30. Sgura FA, Bertelli L, Monopoli D et al (2010) Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST- elevationmyocardial infarction. Circ Cardiovasc Interv 3:491–498

    Article  PubMed  Google Scholar 

Download references

Compliance with ethical guidelines

Conflict of interest. S. Kul, H. Uyarel, O.T. Kucukdagli, M. Turfan, M.A. Vatankulu, A. Tasal, E. Erdogan, E. Asoglu, M. Sahin, T.S. Guvenc, and O. Goktekin state that there are no conflicts of interest. All studies on humans described in the present manuscript were carried out with the approval of the responsible ethics committee and in accordance with national law and the Helsinki Declaration of 1975 (in its current, revised form). Informed consent was obtained from all patients included in studies.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Kul MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kul, S., Uyarel, H., Kucukdagli, O. et al. Zwolle risk score predicts contrast-induced acute kidney injury in STEMI patients undergoing PCI. Herz 40, 109–115 (2015). https://doi.org/10.1007/s00059-013-3957-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00059-013-3957-1

Keywords

Schlüsselwörter

Navigation